{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T12:08:48Z","timestamp":1779451728509,"version":"3.53.1"},"reference-count":16,"publisher":"Media Sphere Publishing House","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Foren. Med. Expert."],"published-print":{"date-parts":[[2026,5,22]]},"abstract":"<jats:p>Objective. To investigate the features of the chemical and toxicological determination of 4-methoxyhydroxybenzene (4-MOHOB). Material and methods. The methods of the study were TLC, reversed-phase column chromatography of ordinary pressure, GC-MS and HPLC. 4-MOHOB was isolated from liver tissue and blood by infusion with a mixture of ethyl \u00abacetate\u2014acetone\u00bb (7:3). Results. The expediency of eluting the analyte from the Silasorb C18 column (150\u00d710 mm) with the mobile phase of \u00abacetonitrile\u2014water\u00bb (4:6) was shown, which in combination with extraction formed the basis for the developed version of purification of 4-MOHOB extracted from biomatrices. The advantages of the \u00abhexane\u2014ether\u00bb (6:4) mobile phase in the identification of 4-MOHOB by TLC (Merck plates) were proven. One of the variants of 4-MOGOB identification is based on its extinction properties (UV range; medium \u2014 95% ethanol). GC-MS (mobile phase \u2014 helium, stationary phase \u00ab5% phenyl\u201495% methylpolysiloxane\u00bb in a column measuring 25 m \u00d7 0.2 mm) was used as the main method of confirmatory identification of 4-MOGOB. The mass spectrum of this compound included signals of the following ions (m\/z): 38, 53, 65, 81, 109, 124. A 250\u00d74.6 mm Discovery C 18 column and an eluent of \u00abacetonitrile\u2014acid-water solution with a pH of 5.5\u00bb (50:50) were proposed for determining 4-MOGOB by HPLC. Conclusion. The compliance of the developed methods with the key validation parameters was confirmed. The detection limits of 4-MOHOB in 100 g of organ (liver) and blood are 0.08 and 0.06 mg, respectively, the limits of quantitative determination are 0.14 and 0.10 mg.<\/jats:p>","DOI":"10.17116\/sudmed20266903135","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T11:33:33Z","timestamp":1779449613000},"page":"35","source":"Crossref","is-referenced-by-count":0,"title":["Chemical-toxicological determination of 4-methoxyhydroxybenzene"],"prefix":"10.17116","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7002-492X","authenticated-orcid":false,"given":"A.P.","family":"Chernova","sequence":"first","affiliation":[{"name":"National Research Tomsk Polytechnic University","place":["Tomsk, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8872-0691","authenticated-orcid":false,"given":"V.K.","family":"Shormanov","sequence":"additional","affiliation":[{"name":"Kursk State Medical University","place":["Kursk, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8944-4358","authenticated-orcid":false,"given":"M.K.","family":"Elizarova","sequence":"additional","affiliation":[{"name":"Yeisk Medical College","place":["Yeisk, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8672-1520","authenticated-orcid":false,"given":"M.V.","family":"Shchitova","sequence":"additional","affiliation":[{"name":"Kursk State Medical University","place":["Kursk, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6743","reference":[{"key":"key-10.17116\/sudmed20266903135-1","doi-asserted-by":"publisher","DOI":"10.17116\/sudmed201659448-53"},{"key":"key-10.17116\/sudmed20266903135-2","doi-asserted-by":"publisher","DOI":"10.4172\/2157-7064.S6-003"},{"key":"key-10.17116\/sudmed20266903135-3","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12571"},{"key":"key-10.17116\/sudmed20266903135-4","doi-asserted-by":"publisher","DOI":"10.2165\/11536930-000000000-00000"},{"key":"key-10.17116\/sudmed20266903135-5","unstructured":"Pi\u00e9rard-Franchimont C, Henry F, Quatresooz P, Vroome V, Pi\u00e9rard GE. Analytic quantification of the bleaching effect of a 4-hydroxyanisole-tretinoin combination on actinic lentigines. Journal of drugs in dermatology. 2008;7(9):873-878"},{"key":"key-10.17116\/sudmed20266903135-6","doi-asserted-by":"publisher","DOI":"10.9734\/JAMPS\/2016\/26655"},{"key":"key-10.17116\/sudmed20266903135-7","unstructured":"National Center for Biotechnology Information. PubChem Compound Summary for CID 9015, Mequinol, PubChem. Accessed 10 January, 2025.  https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Mequinol"},{"key":"key-10.17116\/sudmed20266903135-8","unstructured":"Mequinol. Human Metabolome Database (HMDB). Accessed 10 January, 2025.  https:\/\/www.hmdb.ca\/metabolites\/HMDB0029696"},{"key":"key-10.17116\/sudmed20266903135-9","unstructured":"4-Methoxyphenol. ILO-WHO International Chemical Safety Cards (ICSCs). Accessed 10 January, 2025.  https:\/\/chemicalsafety.ilo.org\/dyn\/icsc\/showcard.display?p_version=2&p_card_id=1097"},{"key":"key-10.17116\/sudmed20266903135-10","unstructured":"Mequinol, SAFETY DATA SHEET. Accessed 10 January, 2025. https:\/\/assets.lgcstandards.com\/sys-master%2Fpdfs%2Fh14%2Fhad%2F10530546614302%2FSDS_LGCFOR1131.00_ST-WB-MSDS-4786700-1-1-1.PDF"},{"key":"key-10.17116\/sudmed20266903135-11","unstructured":"Dobroriz AM, Borisenko AN, Kliza VV. A case of death from eugenol poisoning. Forensic Medical Expertise. 2004;47(5):45-46"},{"key":"key-10.17116\/sudmed20266903135-12","unstructured":"Astashkina AP, Shormanov VK, Kirichek AV, Simonov EA, Sukhomlinova EA, Grishechko OI. Determination of 2-metoxy-4-allylhydroxybenzene during chemico-toxicological studies of the biological materials. Forensic Medical Expertise. 2012;55(6):42-45. (In Russ.)"},{"key":"key-10.17116\/sudmed20266903135-13","doi-asserted-by":"publisher","DOI":"10.1097\/01.jom.0000165016.71465.7a"},{"key":"key-10.17116\/sudmed20266903135-14","unstructured":"Shormanov VK, Kovalenko EA, Duritsyn EP, Maslov SV, Galushkin SG, Pronichenko EI. Determination of carbofuran in the biological material for the purpose of forensic medical examination. Forensic Medical Expertise. 2013;56(4):30-34. (In Russ.)"},{"key":"key-10.17116\/sudmed20266903135-15","unstructured":"Guidance for Industry: Bioanalytical method validation. Washington, DC: HHS\/ FDA\/CDER; 2001"},{"key":"key-10.17116\/sudmed20266903135-16","unstructured":"Metodicheskie rekomendacii po validacii analiticheskih metodik, ispol\u2019zuemyh v sudebno-himicheskom i himiko-toksikologicheskom analize biologicheskogo materiala. M.: EsPeHa; 2014. (In Russ.)"}],"container-title":["Forensic Medical Expertise"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T11:33:47Z","timestamp":1779449627000},"score":1,"resource":{"primary":{"URL":"https:\/\/mediasphera.ru\/issues\/sudebno-meditsinskaya-ekspertiza\/2026\/3\/1003945212026031035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5,22]]}},"alternative-id":["10.17116\/sudmed20266903135"],"URL":"https:\/\/doi.org\/10.17116\/sudmed20266903135","relation":{},"ISSN":["0039-4521"],"issn-type":[{"value":"0039-4521","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,22]]}}}